Texas 2013 83rd Regular

Texas Senate Bill SB1643 Enrolled / Bill

Download
.pdf .doc .html
                    S.B. No. 1643


 AN ACT
 relating to the monitoring of prescriptions for certain controlled
 substances; providing penalties.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Section 481.002, Health and Safety Code, is
 amended by amending Subdivisions (20) and (32) and adding
 Subdivision (54) to read as follows:
 (20)  "Hospital" means:
 (A)  a general or special hospital as defined by
 Section 241.003 [(Texas Hospital Licensing Law)]; [or]
 (B)  an ambulatory surgical center licensed under
 Chapter 243 [by the Texas Department of Health] and approved by the
 federal government to perform surgery paid by Medicaid on patients
 admitted for a period of not more than 24 hours; or
 (C)  a freestanding emergency medical care
 facility licensed under Chapter 254.
 (32)  "Patient" means a human for whom or an animal for
 which a drug:
 (A)  is administered, dispensed, delivered, or
 prescribed by a practitioner; or
 (B)  is intended to be administered, dispensed,
 delivered, or prescribed by a practitioner.
 (54)  "Health information exchange" means an
 organization that:
 (A)  assists in the transmission or receipt of
 health-related information among organizations transmitting or
 receiving the information according to nationally recognized
 standards and under an express written agreement;
 (B)  as a primary business function, compiles or
 organizes health-related information that is designed to be
 securely transmitted by the organization among physicians, health
 care providers, or entities within a region, state, community, or
 hospital system; or
 (C)  assists in the transmission or receipt of
 electronic health-related information among physicians, health
 care providers, or entities within:
 (i)  a hospital system;
 (ii)  a physician organization;
 (iii)  a health care collaborative, as
 defined by Section 848.001, Insurance Code;
 (iv)  an accountable care organization
 participating in the Pioneer Model under the initiative by the
 Innovation Center of the Centers for Medicare and Medicaid
 Services; or
 (v)  an accountable care organization
 participating in the Medicare shared savings program under 42
 U.S.C. Section 1395jjj.
 SECTION 2.  Section 481.076, Health and Safety Code, is
 amended by amending Subsections (a) and (e) and adding Subsections
 (a-1) and (a-2) to read as follows:
 (a)  The director may not permit any person to have access to
 information submitted to the director under Section 481.074(q) or
 481.075 except:
 (1)  an investigator for the Texas Medical Board, the
 Texas State Board of Podiatric Medical Examiners, the State Board
 of Dental Examiners, the State Board of Veterinary Medical
 Examiners, the Texas Board of Nursing, or the Texas State Board of
 Pharmacy;
 (2)  an authorized officer or member of the department
 engaged in the administration, investigation, or enforcement of
 this chapter or another law governing illicit drugs in this state or
 another state; or
 (3)  if the director finds that proper need has been
 shown to the director:
 (A)  a law enforcement or prosecutorial official
 engaged in the administration, investigation, or enforcement of
 this chapter or another law governing illicit drugs in this state or
 another state;
 (B)  a pharmacist or a pharmacy technician, as
 defined by Section 551.003, Occupations Code, acting at the
 direction of a pharmacist or a practitioner who is a physician,
 dentist, veterinarian, podiatrist, or advanced practice nurse or is
 a physician assistant described by Section 481.002(39)(D) or a
 nurse licensed under Chapter 301, Occupations Code, acting at the
 direction of a practitioner and is inquiring about a recent
 Schedule II, III, IV, or V prescription history of a particular
 patient of the practitioner; or
 (C)  a pharmacist or practitioner who is inquiring
 about the person's own dispensing or prescribing activity.
 (a-1)  A person authorized to receive information under
 Subsection (a)(3)(B) or (C) may access that information through a
 health information exchange, subject to proper security measures to
 ensure against disclosure to unauthorized persons.
 (a-2)  A person authorized to receive information under
 Subsection (a)(3)(B) may include that information in any form in
 the medical or pharmacy record of the patient who is the subject of
 the information. Any information included in a patient's medical
 or pharmacy record under this subsection is subject to any
 applicable state or federal confidentiality or privacy laws.
 (e)  The director shall remove from the information
 retrieval system, destroy, and make irretrievable the record of the
 identity of a patient submitted under this section to the director
 not later than the end of the 36th [12th] calendar month after the
 month in which the identity is entered into the system. However,
 the director may retain a patient identity that is necessary for use
 in a specific ongoing investigation conducted in accordance with
 this section until the 30th day after the end of the month in which
 the necessity for retention of the identity ends.
 SECTION 3.  Subsection (a), Section 481.127, Health and
 Safety Code, is amended to read as follows:
 (a)  A person commits an offense if the person knowingly
 gives, permits, or obtains unauthorized access to information
 submitted to the director under Section 481.074(q) or 481.075.
 SECTION 4.  Chapter 481, Health and Safety Code, is amended
 by adding Subchapter I to read as follows:
 SUBCHAPTER I.  INTERAGENCY PRESCRIPTION MONITORING WORK GROUP
 Sec. 481.351.  INTERAGENCY PRESCRIPTION MONITORING WORK
 GROUP. The interagency prescription monitoring work group is
 created to evaluate the effectiveness of prescription monitoring
 under this chapter and offer recommendations to improve the
 effectiveness and efficiency of recordkeeping and other functions
 related to the regulation of dispensing controlled substances by
 prescription.
 Sec. 481.352.  MEMBERS. The work group is composed of:
 (1)  the director or the director's designee;
 (2)  the commissioner of state health services or the
 commissioner's designee;
 (3)  the executive director of the Texas State Board of
 Pharmacy or the executive director's designee;
 (4)  the executive director of the Texas Medical Board
 or the executive director's designee;
 (5)  the executive director of the Texas Board of
 Nursing or the executive director's designee; and
 (6)  the executive director of the Texas Physician
 Assistant Board or the executive director's designee.
 Sec. 481.353.  MEETINGS. (a)  The work group shall meet at
 least quarterly.
 (b)  The work group is subject to Chapter 551, Government
 Code.
 (c)  The work group shall proactively engage stakeholders
 and solicit and take into account input from the public.
 Sec. 481.354.  REPORT.  Not later than December 1 of each
 even-numbered year, the work group shall submit to the legislature
 its recommendations relating to prescription monitoring.
 SECTION 5.  Section 168.102, Occupations Code, is amended by
 adding Subsection (d) to read as follows:
 (d)  If an applicant for a certificate under this chapter is
 under investigation by the board for a violation of this subtitle,
 board rules, or other law relating to the prescription,
 dispensation, administration, supply, or sale of a controlled
 substance, the board may not make a decision on the application
 until the board has reached a final decision on the matter under
 investigation.
 SECTION 6.  Subsection (a), Section 168.202, Occupations
 Code, is amended to read as follows:
 (a)  A violation of this chapter or a rule adopted under this
 chapter is grounds for disciplinary action, including a temporary
 suspension or restriction under Section 164.059, against a pain
 management clinic certified under this chapter or an owner or
 operator of a clinic certified under this chapter.
 SECTION 7.  This Act takes effect September 1, 2013.
 ______________________________ ______________________________
 President of the Senate Speaker of the House
 I hereby certify that S.B. No. 1643 passed the Senate on
 April 25, 2013, by the following vote: Yeas 28, Nays 0; and that
 the Senate concurred in House amendments on May 25, 2013, by the
 following vote: Yeas 30, Nays 0.
 ______________________________
 Secretary of the Senate
 I hereby certify that S.B. No. 1643 passed the House, with
 amendments, on May 22, 2013, by the following vote: Yeas 144,
 Nays 2, one present not voting.
 ______________________________
 Chief Clerk of the House
 Approved:
 ______________________________
 Date
 ______________________________
 Governor